Most Expensive
request_quoteIndulge in the exquisite details and unparalleled quality of the most expensive products and assets that define luxury living.
| name | Price | $ Change | % Change | Market Cap | Volume | Avg. Volume | arrow_downwardPE Ratio | Technicals | Dividend Y | ROI 1Y | Score language | Last 7 Days | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
YMABY-mAbs Therapeutics | $4.26 | $0.04 | arrow_drop_up0.96% | $174.79M | 143.82K | 4.15 | - | Neutralremove | - | -66.80% | |||||
DLY DLYDoubleline Yield Opportunities Fund | $15.39 | $0.01 | arrow_drop_up0.09% | $748.35M | 70.42K | 15.37 | - | Neutralremove | - | -2.26% | |||||
BIPCBrookfield Infrastructure | $39.66 | $0.59 | arrow_drop_up1.52% | $4.63B | 487.26K | 39.56 | - | Neutralremove | 4.02% | 10.90% | |||||
OCULOcular Therapeutix | $7.22 | -$0.01 | arrow_drop_down0.20% | $1.14B | 1.20M | 7.21 | - | Neutralremove | - | 20.45% | |||||
WULFTeraWulf | $3.93 | -$0.13 | arrow_drop_down3.17% | $1.35B | 39.92M | 3.93 | - | Neutralremove | - | 82.17% | |||||
MDMEDNAX | $13.49 | -$0.50 | arrow_drop_down3.61% | $1.27B | 1.05M | 13.57 | - | Neutralremove | - | 79.15% | |||||
BBUCBrookfield Business | $28.64 | $0.44 | arrow_drop_up1.55% | $2.09B | 30.75K | 28.59 | - | Neutralremove | 0.91% | 38.82% | |||||
 DANDana | $16.46 | $0.31 | arrow_drop_up1.91% | $2.34B | 1.21M | 16.32 | - | Neutralremove | 2.69% | 18.96% | |||||
MITAColiseum Acquisition | $11.51 | $11.51 | 0.00% | $63.73M | 35.85K | 11.34 | - | Neutralremove | - | - | |||||
PRCTPROCEPT BioRobotics Corporation | $57.24 | -$0.54 | arrow_drop_down0.93% | $3.21B | 286.40K | 57.00 | - | Neutralremove | - | -14.64% | |||||
NVOSNovo Integrated Sciences | $0.14 | -$0.01 | arrow_drop_down11.32% | $1.15M | 3.24M | 0.15 | - | Neutralremove | - | -68.09% | |||||
ARQTArcutis Biotherapeutics | $13.93 | $0.25 | arrow_drop_up1.86% | $1.62B | 978.03K | 13.70 | - | Neutralremove | - | 40.42% | |||||
IRONDisc Medicine | $47.29 | -$0.89 | arrow_drop_down1.86% | $1.63B | 71.56K | 47.26 | - | Neutralremove | - | 42.56% | |||||
 EXTRExtreme Networks | $15.44 | -$0.40 | arrow_drop_down2.52% | $2.17B | 554.30K | 15.50 | - | Neutralremove | - | 35.22% | |||||
SPTSprout Social | $21.29 | -$0.36 | arrow_drop_down1.65% | $1.38B | 289.21K | 21.36 | - | Neutralremove | - | -33.61% | |||||
KALAKala Pharmaceuticals | $3.92 | -$0.16 | arrow_drop_down4.03% | $20.77M | 11.91K | 3.95 | - | Neutralremove | - | -39.70% | |||||
TARSTarsus Pharmaceuticals | $43.08 | $0.09 | arrow_drop_up0.20% | $1.82B | 160.88K | 42.87 | - | Neutralremove | - | 20.42% | |||||
AIO AIOAllianzGI Artificial Intelligence & Technology Opportunities Fund | $22.49 | -$0.13 | arrow_drop_down0.57% | $778.68M | 19.06K | 22.49 | - | Neutralremove | - | 12.47% | |||||
WLYJohn Wiley & Sons | $40.81 | -$0.23 | arrow_drop_down0.58% | $2.35B | 252.49K | 40.62 | - | Neutralremove | 3.54% | 8.55% | |||||
BNH BNHBrookfield Finance Inc. 4.625% Subordinated Notes due October 16, 2080 | $15.31 | $0.06 | arrow_drop_up0.39% | $0.00 | 9.41K | 15.31 | - | Neutralremove | - | -10.04% |
Showing 4761-4780 of 4978
Results per page:
About Most Expensive
Discover the world of the most expensive stocks, where share prices reach extraordinary heights. These stocks command premium valuations, reflecting investor confidence and perceived value in the companies.
Investors seeking prestigious opportunities may find these high-priced stocks alluring, as they often represent established and successful companies with strong market positions.
Discover the Power of Stocklytics Tools
Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.
See Stocklytics Tools